Alterations of Gut Microbiome and Serum Metabolome in Coronary Artery Disease Patients Complicated With Non-alcoholic Fatty Liver Disease Are Associated With Adverse Cardiovascular Outcomes

Alterations of Gut Microbiome and Serum Metabolome in Coronary Artery Disease Patients Complicated With Non-alcoholic Fatty Liver Disease Are Associated With Adverse Cardiovascular Outcomes

Rationale: Patients suffering from coronary artery disease (CAD) complicated with nonalcoholic fatty liver disease (NAFLD) present worse cardiovascular outcomes than CAD patients without NAFLD. The progression of CAD is recently reported to be associated with gut microbiota and microbe-derived metab...

Full description

Bibliographic Details
Main Authors: Xiaomin Hu, Ruilin Zhou, Hanyu Li, Xinyue Zhao, Yueshen Sun, Yue Fan, Shuyang Zhang
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-01-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
coronary heart disease
non-alcoholic fatty liver disease
microbiome
metabolome
cardiovascular outcomes
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2021.805812/full

Internet

https://www.frontiersin.org/articles/10.3389/fcvm.2021.805812/full

Similar Items